흉골 폐쇄 시스템 시장 : 제품 유형, 소재, 디바이스 사용성, 용도, 최종 사용자, 유통 채널별 예측(2026-2032년)

The Sternal Closure Systems Market is projected to grow by USD 7.18 billion at a CAGR of 13.20% by 2032.

The sternal closure systems market is anchored by the continued clinical importance of median sternotomy in open cardiac surgery, including coronary artery bypass grafting, valve repair and replacement, aortic surgery, congenital cardiac procedures, and complex reoperations. Sternal closure devices such as stainless-steel wires, titanium plates, cable systems, bands, clips, and rigid fixation solutions are used to stabilize the sternum, support bone healing, reduce micromotion, and lower the risk of post-sternotomy complications after thoracic access.

Demand is shaped by the global burden of cardiovascular disease, aging populations, higher prevalence of obesity and diabetes, and the ongoing need for safe post-operative recovery in high-risk cardiac surgery patients. The World Health Organization identifies cardiovascular disease as the leading cause of death globally, while peer-reviewed cardiothoracic literature consistently links sternal instability, dehiscence, and deep sternal wound infection with longer hospital stays, higher readmission risk, reintervention, and increased care costs. As a result, hospitals, surgeons, and procurement teams are increasingly evaluating sternal closure systems not only by device cost, but also by clinical outcomes, ease of use, infection risk reduction, procedural efficiency, and compatibility with enhanced recovery pathways.

Transformative Shifts in Sternal Closure

The sternal closure landscape is moving from conventional wire cerclage alone toward risk-adjusted closure strategies. Traditional stainless-steel wire remains widely used due to familiarity, speed, broad availability, and low acquisition cost, but rigid plate fixation and hybrid closure techniques are gaining attention for patients with obesity, osteoporosis, chronic obstructive pulmonary disease, diabetes, chronic kidney disease, reoperation risk, or other factors associated with impaired sternal healing.

Device innovation is focused on pre-contoured plates, low-profile implants, cable and band systems, reusable and single-use instrumentation, and procedure-specific kits designed to reduce operating room variability and support consistent fixation. At the same time, value-based purchasing is shifting the market conversation toward total episode cost, including prevention of sternal dehiscence, mediastinitis, reintervention, prolonged intensive care utilization, and delayed rehabilitation. Regulatory scrutiny, sterilization requirements, unique device identification, implant traceability, and evidence expectations are also encouraging better post-market surveillance and stronger clinical differentiation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the sternal closure systems market through clinical decision support, imaging analysis, and operational optimization. AI-enabled risk models can help identify patients at elevated risk for sternal wound complications by combining variables such as body mass index, diabetes status, renal function, smoking history, bone quality, chronic lung disease, procedure type, infection history, and reoperative status. These tools can support more consistent selection of wire, rigid plate fixation, or hybrid closure approaches when validated within cardiac surgery workflows.

AI also has practical applications in preoperative CT assessment, sternal bone quality evaluation, surgical planning, inventory management, quality reporting, and post-operative monitoring. Computer vision and predictive analytics can support earlier recognition of wound complications, while hospital supply-chain algorithms can reduce stockouts for plates, screws, wires, and dedicated instruments. Adoption will depend on validated datasets, integration with electronic health records, surgeon acceptance, cybersecurity, explainability, and transparent evidence showing that AI-supported closure decisions improve outcomes without adding workflow burden.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East & Africa

Asia-Pacific is becoming a prominent growth region for sternal closure systems as China, India, Japan, South Korea, Australia, and ASEAN healthcare systems expand cardiac surgery capacity and invest in tertiary care infrastructure. Rising cardiovascular disease prevalence, aging populations in developed Asia, medical tourism, private hospital networks, and broader access to advanced procedures support demand for both cost-efficient wire closure and premium rigid fixation solutions. Public health data show that cardiovascular disease is a major cause of mortality across the region, while hospital modernization is increasing access to complex cardiothoracic interventions.

North America remains a leading innovation and adoption region, supported by advanced cardiac centers, established reimbursement pathways, strong surgeon training, and demand for outcome-based technologies in high-risk sternotomy patients. Europe emphasizes clinical evidence, procurement discipline, implant traceability, and regulatory compliance under the EU medical device framework, creating opportunities for differentiated products with strong safety, performance, and post-market data. Across both regions, infection prevention, readmission reduction, and enhanced recovery protocols are central to purchasing decisions.

Latin America shows selective adoption driven by Brazil, Mexico, and private hospital systems, while budget constraints keep wire-based systems important in public procurement. The Middle East is benefiting from investment in specialty cardiac centers, particularly across Gulf health systems, where premium device adoption is supported by hospital modernization and high prevalence of diabetes and obesity-related cardiovascular risk. Africa remains an emerging market with uneven access to advanced cardiac surgery, but long-term opportunities are tied to cardiac care infrastructure development, workforce training, donor-supported capacity building, and partnerships that improve affordability, availability, and surgical education.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7 & NATO

ASEAN demand is shaped by expanding private healthcare, medical tourism, and rising cardiac procedure capability in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. Hospitals in the region balance affordability with the need for reliable post-sternotomy outcomes, creating room for tiered product portfolios that include wires, cables, bands, and rigid fixation systems for selected high-risk patients.

The GCC is an important premium opportunity due to investments in advanced cardiac care, national health transformation programs, and growing treatment of diabetes- and obesity-related cardiovascular disease. The European Union favors clinically proven technologies that align with procurement standards, Medical Device Regulation compliance, traceability, sustainability expectations, and evidence-based purchasing. BRICS countries represent a large-volume opportunity because of population scale, cardiovascular disease burden, and hospital modernization, although pricing pressure, localization policies, and public-sector procurement requirements can shape market entry strategies.

G7 markets are characterized by sophisticated cardiac surgery programs, stronger evidence requirements, mature reimbursement systems, and adoption of technologies that demonstrate reduced complications or improved recovery. NATO countries overlap heavily with North American and European healthcare systems, where supply resilience, regulatory quality, implant availability, and dependable access to surgical devices have become more important following recent global supply-chain disruptions and heightened attention to healthcare preparedness.

Key Country Insights Across Major Markets

The United States is the most influential country market for sternal closure systems due to its concentration of high-volume cardiac centers, strong adoption of advanced fixation technologies, and focus on reducing post-operative complications, readmissions, and total episode cost. Canada follows evidence-led adoption through publicly funded systems that emphasize clinical value and standardized procurement, while Mexico combines public-sector cost sensitivity with private hospital demand for advanced cardiac devices. Brazil is Latin America's key country opportunity because of its established cardiac surgery base, large patient population, and private healthcare segment.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show steady demand supported by mature cardiac surgery programs and increased attention to quality metrics, infection prevention, and device traceability. Germany remains especially important for medical technology adoption, clinical specialization, and manufacturing strength, while France, Italy, and Spain balance premium use with centralized or regional procurement. Russia maintains demand through large cardiac care needs, though procurement dynamics and access to imported technologies can be affected by geopolitical, regulatory, and economic conditions.

In Asia-Pacific, China and India provide substantial long-term procedure potential due to large cardiovascular patient populations, rising access to specialty hospitals, and ongoing healthcare infrastructure expansion, while Japan emphasizes high-quality devices, aging-related cardiac care, procedural reliability, and stringent regulatory standards. Australia has a sophisticated hospital environment with evidence-driven purchasing and strong clinical governance, and South Korea combines advanced surgical capability with strong medtech infrastructure, digital health adoption, and interest in innovative fixation solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize risk-stratified product portfolios that support both standard sternotomy closure and complex, high-risk patients. A competitive portfolio should include reliable wires, cables or bands, rigid plate fixation systems, low-profile implants, ergonomic instruments, and procedure-ready kits that simplify surgeon choice, reduce operating room variability, and support hospital purchasing efficiency.

Organizations should invest in clinical evidence that links device selection to measurable outcomes such as sternal stability, infection reduction, reoperation avoidance, pain reduction, respiratory recovery, and length-of-stay improvement. Partnerships with cardiac centers, surgeon education programs, registry participation, and real-world evidence generation can strengthen market access. Manufacturers should also build resilient supply chains, support regional regulatory requirements, explore AI-enabled planning and risk-assessment tools, and design pricing strategies that address both premium hospitals and cost-constrained emerging markets.

Research Methodology

This executive summary is built on a structured research methodology combining secondary research, clinical literature review, regulatory assessment, and evidence triangulation. Sources considered include peer-reviewed cardiothoracic surgery publications, public health data, hospital procedure trends, regulatory frameworks, product category information, reimbursement dynamics, and macroeconomic indicators relevant to cardiac care infrastructure and surgical capacity.

The analysis evaluates demand drivers, product evolution, regional adoption patterns, group-level characteristics, country-level opportunities, and technology trends affecting sternal closure systems. Insights are validated through cross-comparison of clinical risk factors, healthcare investment patterns, cardiovascular disease burden, procurement behavior, regulatory expectations, and device adoption indicators to provide a balanced, evidence-oriented view for industry decision-makers without relying on market sizing, share estimates, or forecasts.

Conclusion

The sternal closure systems market is evolving from a commodity-oriented closure category into a clinically strategic segment of cardiac surgery. Wire closure will remain essential because of cost efficiency, broad availability, and long-standing surgeon familiarity, but rigid fixation, hybrid approaches, and patient-specific closure strategies are gaining importance as hospitals seek to reduce complications, improve stability, and support faster recovery after median sternotomy.

Future industry direction will be shaped by cardiovascular procedure demand, aging and higher-risk surgical populations, expanding cardiac care infrastructure, stronger evidence for outcome-based device selection, and growing use of digital tools in perioperative decision-making. Organizations that combine dependable products, clinical education, AI-enabled decision support, regulatory quality, resilient supply chains, and region-specific access strategies will be best positioned to create value in the global sternal closure systems landscape.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Sternal Closure Systems Market, by Product Type

• 7.1. Rigid Fixation Devices
  • 7.1.1. Plates & Screws Systems
  • 7.1.2. Interlocking Sternum Closure Devices
  • 7.1.3. Clamp-based Systems
• 7.2. Semirigid Fixation Devices
  • 7.2.1. Cable & Wire Systems
  • 7.2.2. Band-based Systems
• 7.3. Flexible Fixation Devices

8. Sternal Closure Systems Market, by Material

• 8.1. Metallic
  • 8.1.1. Stainless Steel
  • 8.1.2. Titanium
• 8.2. Non-metallic

9. Sternal Closure Systems Market, by Device Usability

• 9.1. Single-use
• 9.2. Reusable Systems

10. Sternal Closure Systems Market, by Application

• 10.1. Median Sternotomy
  • 10.1.1. Cardiac Surgery
  • 10.1.2. Congenital Heart Defect Repair
• 10.2. Reoperative Sternotomy
• 10.3. Trauma/Orthopedic Sternotomy

11. Sternal Closure Systems Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Clinics
• 11.3. Hospitals
• 11.4. Cardiac Specialty Clinics
• 11.5. Trauma Centers

12. Sternal Closure Systems Market, by Distribution Channel

• 12.1. Offline
• 12.2. Online

13. Sternal Closure Systems Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Sternal Closure Systems Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Sternal Closure Systems Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Applus Services, S.A.
• 17.2. BioAgilytix Labs, LLC
• 17.3. BSI Group
• 17.4. Bureau Veritas SA
• 17.5. Charles River Laboratories International, Inc.
• 17.6. CSA Group
• 17.7. DEKRA SE
• 17.8. DNV GL AS
• 17.9. Element Materials Technology Group Limited
• 17.10. Eurofins Scientific SE
• 17.11. Frontage Laboratories, Inc.
• 17.12. ICON Public Limited Company
• 17.13. Intertek Group plc
• 17.14. Laboratory Corporation of America Holdings
• 17.15. Medistri SA
• 17.16. Nelson Laboratories, LLC
• 17.17. North American Science Associates, LLC
• 17.18. NSF International
• 17.19. Pace Analytical Services, LLC
• 17.20. SGS Societe Generale de Surveillance SA
• 17.21. Smithers Group, Inc.
• 17.22. Sotera Health Company
• 17.23. Toxikon Corporation
• 17.24. TUV Rheinland AG
• 17.25. TUV SUD AG
• 17.26. UL Solutions Inc.
• 17.27. WuXi AppTec Co., Ltd.